Published:
Novo Nordisk said game on, as the Denmark-based drugmaker lowered prices on its obesity treatment Wegovy for those without insurance, and said it would deliver the drug to their homes.
The company’s
NVO move comes a week after Eli Lilly & Co. LLY cut prices for its rival weight-loss drug Zepbound.
Read the full article here
Published: March 5, 2025 at 5:30 p.m. ETKroger, the biggest U.S. supermarket chain…
The Trump administration is widening its assault against government spending on consultants,…
Published: March 5, 2025 at 5:32 p.m. ETBank stocks have taken the broader…
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…
Published: March 5, 2025 at 5:28 p.m. ETWhat might the “Big Three” U.S.…
